| Literature DB >> 28589520 |
Eun-Joo Shin1, Hai-Quyen Tran1, Phuong-Tram Nguyen1, Ji Hoon Jeong2, Seung-Yeol Nah3, Choon-Gon Jang4, Toshitaka Nabeshima5, Hyoung-Chun Kim6.
Abstract
Methamphetamine (MA), an amphetamine-type psychostimulant, is associated with dopaminergic toxicity and has a high abuse potential. Numerous in vivo and in vitro studies have suggested that impaired mitochondria are critical in dopaminergic toxicity induced by MA. Mitochondria are important energy-producing organelles with dynamic nature. Evidence indicated that exposure to MA can disturb mitochondrial energetic metabolism by inhibiting the Krebs cycle and electron transport chain. Alterations in mitochondrial dynamic processes, including mitochondrial biogenesis, mitophagy, and fusion/fission, have recently been shown to contribute to dopaminergic toxicity induced by MA. Furthermore, it was demonstrated that MA-induced mitochondrial impairment enhances susceptibility to oxidative stress, pro-apoptosis, and neuroinflammation in a positive feedback loop. Protein kinase Cδ has emerged as a potential mediator between mitochondrial impairment and oxidative stress, pro-apoptosis, or neuroinflammation in MA neurotoxicity. Understanding the role and underlying mechanism of mitochondrial impairment could provide a molecular target to prevent or alleviate dopaminergic toxicity induced by MA.Entities:
Keywords: Apoptosis; Dopaminergic toxicity; Methamphetamine; Mitochondria; Protein kinase Cδ
Mesh:
Substances:
Year: 2017 PMID: 28589520 DOI: 10.1007/s11064-017-2318-5
Source DB: PubMed Journal: Neurochem Res ISSN: 0364-3190 Impact factor: 3.996